Eisai Co., Ltd. Skip Navigation Top menu Japanese | English
| Sitemap |

Main contents
Eisai Global Site
Eisai Global Site

Investor Relations

Environmental and Social Report

about Eisai

VITAMIN E
Potential Suppliers

Inquiry

human health care
       
Understanding Eisai Understanding Eisai
Company Introduction Video Company Introduction Video
Annual Report Annual Report 2008
Environmental and Social Report Environmental and Social Report 2008

News Release
List
December 15, 2008
FDA Approves Sedative-Hypnotic Agent LUSEDRA™ Injection
November 17, 2008
FDA Approves BANZEL™ (rufinamide) as Adjunctive Treatment for Lennox-Gastaut Syndrome
November 11, 2008
Eisai Completes Alliance Agreement with TorreyPines Therapeutics for Genetic Research Programs to Discover Genes Associated with LOAD
-New Agreement Signed for Eisai to Purchase Research Assets-

What's New
List
December 26, 2008
Commitment & Passion for hhc “Beyond the doctor,there are always patients”
December 24, 2008
Environmental and Social Report - Opinions from Stakeholders
“Patients want their voices to be heard.(Mr. Norio Sasaki)”
December 17, 2008
Environmental and Social Report - Opinions from Stakeholders
“I hope Eisai becomes a good partner in bringing happiness to the individual and to society (Mr. Tomoyuki Mochizuki)”

Information
MORPHOTEK®, INC. Announces Research Agreement with The University of Pennsylvania to Develop Oncology Therapeutic Antibody Candidates (December 24, 2008)
Corporate Governance Report updated (July 31, 2008)
Bottom menu
   Privacy Policy  |  Terms of Use  |  Accessibility
Copyright(C) Eisai Co., Ltd. All rights reserved.